Role of immunohistochemical detection of lymph-node metastases in management of breast cancer
暂无分享,去创建一个
B. Gusterson | R. Cote | A. Goldhirsch | M. Castiglione‐Gertsch | R. Gelber | A Goldhirsch | B. Chaiwun | R. Cote | H. Fpeterson | Amber Neville | B Chaiwun | RJ Cote | H Fpeterson | RD Gelber | M Castiglione-Gertsch | B Gusterson | AM Neville | Neville Am
[1] C. Redmond,et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update , 1983, Cancer.
[2] J. Coindre,et al. Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. , 1987, British Journal of Cancer.
[3] A. Lee,et al. Occult axillary lymph node metastases in "node-negative" breast carcinoma. , 1993, Human pathology.
[4] M. Zelen,et al. Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. , 1989, The New England journal of medicine.
[5] Umberto Veronesi,et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes , 1997, The Lancet.
[6] O. Saphir,et al. Obscure axillary lymph‐node metastasis in carcinoma of the breast , 1948, The American journal of pathology.
[7] S. Braun,et al. Re: Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. , 1996, Journal of the National Cancer Institute.
[8] J. Sloane,et al. Micrometastases in breast cancer: long-term follow-up of the first patient cohort. , 1991, European journal of cancer.
[9] M L Lesser,et al. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Screening for human immunodeficiency virus infections. , 1989, The New England journal of medicine.
[11] Internationalludwigbreastcanc. Prognostic importance of occult axillary lymph node micrometastases from breast cancers , 1990 .
[12] O. Saphir,et al. Obscure axillary lymph node metastases in carcinoma of the breast. , 1948, The Proceedings of the Institute of Medicine of Chicago.
[13] D. Neuberg,et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] D. Sedmak,et al. Prognostic significance of cytokeratin-positive breast cancer metastases. , 1989, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[15] J. Izbicki,et al. Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] C. V. D. van de Velde,et al. Micrometastases and survival in stage II colorectal cancer. , 1998, The New England journal of medicine.
[17] A. Cochran,et al. Occult Tumor Cells in the Lymph Nodes of Patients with Pathological Stage I Malignant Melanoma An Immunohistological Study , 1988, The American journal of surgical pathology.
[18] T. Powles,et al. DETECTION OF MICROMETASTASES IN PATIENTS WITH PRIMARY BREAST CANCER , 1983, The Lancet.
[19] R. Cote,et al. Antigen Retrieval Immunohistochemistry: Past, Present, and Future , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[20] J. Forbes,et al. Present and future projects of the international breast cancer study group , 1994, Cancer.
[21] A. Niendorf,et al. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. , 1997, The New England journal of medicine.
[22] W. McGuire,et al. Prognostic factors in breast cancer. , 1989, Seminars in surgical oncology.
[23] J. Tjandra,et al. Detection and significance of occult metastases in node‐negative breast cancer , 1993, The British journal of surgery.